Goldman Sachs’s ADARx Pharmaceuticals ADRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ADRX
SL
Goldman Sachs's ADRX Position: Q3 2026 in Review
Goldman Sachs opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 181,300 shares worth $3.62M. The stake represents ﹤0.01% of the portfolio and ranks #4190 among its holdings.
62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.
- Goldman Sachs held 181,300 shares of ADARx Pharmaceuticals worth $3.62M as of Q3 2026.
- ADARx Pharmaceuticals was a new Goldman Sachs position in Q3 2026.
- ADARx Pharmaceuticals made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #4190 holding.
- 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.
Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.